Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer immunotherapy

Making allies of phagocytes

A versatile nanovaccine platform is based on a synthetic nanoparticle that not only acts as an antigen carrier but also stimulates the STING pathway.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic illustration of the minimalist design of the PC7A nanovaccine.

References

  1. Luo, M. et al. Nat. Nanotech. 12, 648–654 (2017).

    Article  CAS  Google Scholar 

  2. Siddiqui, M. et al. BioDrugs 5, 313–316 (2006).

    Article  Google Scholar 

  3. Cubillos-Ruiz, J. R. et al. J. Clin. Invest. 119, 2231–2244 (2009).

    CAS  Google Scholar 

  4. Lizotte, P. H. et al. Nat. Nanotech. 11, 295–303 (2016).

    Article  CAS  Google Scholar 

  5. Ishikawa, H. et al. Nature 455, 674–678 (2008).

    Article  CAS  Google Scholar 

  6. Corrales, L. et al. J. Clin. Invest. 126, 2404–2411 (2016).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Fiering.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiering, S. Making allies of phagocytes. Nature Nanotech 12, 615–616 (2017). https://doi.org/10.1038/nnano.2017.89

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2017.89

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing